Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

PURPOSE: The β(¯)-emitting terbium-161 also emits conversion and Auger electrons, which are believed to be effective in killing single cancer cells. Terbium-161 was applied with somatostatin receptor (SSTR) agonists that localize in the cytoplasm (DOTATOC) and cellular nucleus (DOTATOC-NLS) or with...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgna, Francesca, Haller, Stephanie, Rodriguez, Josep M. Monné, Ginj, Mihaela, Grundler, Pascal V., Zeevaart, Jan Rijn, Köster, Ulli, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921065/
https://www.ncbi.nlm.nih.gov/pubmed/34625828
http://dx.doi.org/10.1007/s00259-021-05564-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921065/
https://www.ncbi.nlm.nih.gov/pubmed/34625828
http://dx.doi.org/10.1007/s00259-021-05564-0

Ejemplares similares